EDGC Appoints Three Co-CEOs Under Rehabilitation Plan, CEO Structure Changed to Joint Representation


  • EDGC is currently under rehabilitation proceedings and has changed its CEO structure from a single representative to three co-CEOs Lee Min Sup, Ma Min Cheol, and Kim Bong Jo through an extraordinary general meeting approved by the Suwon Rehabilitation Court.
  • This change is part of the rehabilitation plan aimed at normalizing management and improving governance, but the ongoing court-supervised process itself signals financial distress that investors should monitor closely.
  • There is no capital change or new share issuance associated with this CEO change, so the existing 225.5 million shares and market cap of 167.1 billion KRW remain unaffected.
  • [AI Summary]EDGC has restructured its leadership under court supervision as part of its rehabilitation plan. While the co-CEO system may enhance decision-making speed and transparency, the company's distressed status under court oversight poses potential downside risk to shareholder value.

KOSDAQ Filing Information


  • Change In Representative Director
  • Company: Eone Diagnomics Genome Center (245620)
  • Submission: Eone Diagnomics Genome Center Co., Ltd.
  • Under KRX KOSDAQ Market Division

  • Shares: 225,531,114
  • Price: 741 KRW
  • Market Cap: 167.1 B KRW